NCT04096105View on ClinicalTrials.gov

Japanese Pharmacokinetic Bridging Study for CC-93538

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

January 29, 2020

Study Completion Date

January 30, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

CC-93538

a single dose CC-93538 SC

Trial Locations (1)

92801

Anaheim Clinical Trials, Anaheim

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY